Global Point of Care Testing Market

Market Overview

The Point of Care Testing Market size was valued at around 49.7 Billion in 2023 and is expected to reach a value of USD 111.56 Billion by 2032, at a CAGR of 9% over the forecast period (2024–2032).

The Global Point of Care Testing (POCT) Market is determined by the necessity of near-patient accurate and rapid diagnostic solutions. POCT allows health care professionals to make immediate clinical decisions by delivering timely results-not only in emergency and critical care situations but also while managing patients with chronic disease. The widespread adoption of point-of-care testing across health care systems-from hospitals and clinics to home care environments-is driven by the need for speedier diagnosis to improve patient outcomes, shorten hospital stays, and cap overall health care costs.

The main technologies that have resulted in the growth of the POCT Market include innovations in miniaturization, integration into digital health tools, improvements in biosensors, microfluidics, and molecular diagnostics. These innovations have improved accuracy, reliability, and ease of use in POCT devices. Growth in the serious incidence of chronic diseases like diabetes, cardiovascular diseases and infectious diseases is expected to further create a demand for regular testing and monitoring.

The change from centralized systems to decentralized health care along with the growing importance of preventive care has also energized interest in POCT. In their global quest toward patient-centric healthcare, point of care testing would certainly supply all the flexibility and convenience required by the evolving healthcare environment. Hence the point of care testing market is expected to continue expanding vigorously in the years to come, facilitated further by coming up with innovations in technology and increasing levels of patient awareness.

Market Drivers

Growing Prevalence of Chronic Diseases

• POCT includes diabetes, cardiovascular diseases, and respiratory diseases that can be monitored regularly with timely diagnosis. These patients require POCT devices for monitoring as well as effective management for both the patient and the health care provider. For instance, glucose monitoring kits can be used by diabetic patients to monitor their blood sugar levels easily without much hassle so that they might adapt their lifestyles and medications accordingly. Convenience and efficiency in managing chronic conditions are what keeps such people moving toward POCT, particularly in home care settings, so that they do not have to travel often for quick results.

Shift Toward Decentralized Healthcare

• Another driving factor is the shift to a decentralized healthcare model, moving care away from centralized acute facilities and closer into home-based care environments. The need for patient-centric solutions is being fueled by an increasing demand for flexibility in care, most notably in the remote and underserved areas. POCT fits within this model: it allows the provider to deliver diagnosis at the point of care, reducing hospitalization and improving access, especially in rural or hard-to-reach areas.

Market Opportunities

Expansion of Personalized Medicine

• POCT's contribution to the expanding field of customized medicine presents a new possibility for the market. Developments in molecular diagnostics, POCT devices can now be customized to evaluate biomarkers, offering personalized health insights. This enhances patient outcomes by enabling more precise, tailored treatment strategies. The need for specific solutions is expected to grow as unique medicine continues to gain popularity.

Integration of Artificial Intelligence (AI)

• Another opportunity is the incorporation of artificial intelligence (AI) into POCT devices. Through real-time analysis of complex data, AI can improve POCT's diagnostic skills and produce faster, more precise diagnoses. Predictive analytics presuming that by AI-powered POCT devices can enhance disease management and preventative care tactics, hence increasing the market potential.

Key Findings:

• The U.S. Food and Drug Administration authorized Cepheid's Xpert HCV test and GeneXpert Xpress System for sale in June 2024. This is the first hepatitis C virus (HCV) test that can be used to diagnose people at risk for hepatitis C in properly certified point-of-care settings. Settings covered by a CLIA (Clinical Laboratory Improvement Amendments) Certificate of Waiver, including some drug rehab centers, prisons, syringe service programs, doctor's offices, emergency rooms, and urgent care centers, may administer the test. Instead of requiring a sample to be sent to a central lab for testing, the test uses a fingertip blood sample to identify HCV RNA and provides results in around an hour.

Market Restraining Factors

Regulatory and Reimbursement Challenges

• The POCT Market has potential and promises many opportunities. However, there are some significant blocks restricting this market's complete accessibility: manufacturers and healthcare providers. Almost all POCT devices would have lengthy approval procedures by stringent regulatory bodies. These, together with obstacles to product development, would postpone product launches and increase development costs. Each of these factors could stand in the way of reimbursement coverage for POCT devices, particularly in emerging markets where healthcare budgets may be low. Therefore, this regulatory landscape presents a considerable challenge that will have to be overcome by most involved industries, such as manufacturers, as they will have to navigate extremely complex approval and reimbursement pathways to get their products into the market.

Segmentation Analysis

The market scope is segmented because of by Product Type, by Platform, by Mode of Purchase, by Application, by End User.

By Product Type

Based on the Product Type of the market is segmented into Glucose Monitoring Kits, Infectious Disease Testing Kits, Cardiometabolic Monitoring Kits, Coagulation Testing Kits, Hematology Testing Kits, Pregnancy and Fertility Testing Kits, Tumor/Cancer Marker Testing Kits, Urinalysis Testing Kits, Cholesterol Testing Kits, Drugs of Abuse Testing Kits.

Among the diverse range of product types in the Point of Care Testing (POCT) Market, Glucose Monitoring Kits have perennially captured the maximum market share. The ever-increasing prevalence of diabetes worldwide has ushered in phenomenal demand for continuous glucose monitoring for management, making this segment the largest of all. As most countries in the world contain millions of new diabetes cases every year, according to the International Diabetes Federation (IDF), a huge population percentage is estimated to have diabetes. This condition continually requires blood glucose monitoring to avert any complications such as hyperglycemia or hypoglycemia. The glucose monitoring kits have therefore become very valuable to patients and their health care providers.

They are also easy to use, helping to ensure the widespread use of glucose monitoring kits. These kits allow diabetic patients to monitor their blood sugar levels at home or on the go, reducing the need for frequent visits to healthcare facilities. This segment is experiencing growth as patient self-care becomes more common, coupled with modern portable devices capable of accurate readings in seconds. At the same time, advancements like continuous glucose monitoring systems also contribute to the growth of the market. These innovations offer real-time data through wearable devices.

By Platform

Based on the Platform of the market is segmented into Lateral Flow Assays, Immunoassays, Molecular Diagnostics, Dipsticks, Microfluidics.

The several platform segments in the Point of Care Testing (POCT) Market, the Lateral Flow Assays (LFAs) have led it. They are extremely user-friendly, inexpensive and highly efficient diagnostic tools that have found immense popularity because of their usefulness in a variety of one-step sample test formats. These include applications for infectious disease detection, pregnancy testing, or drugs of abuse testing, because they detect specific antigens or antibodies in any of several bodily samples, including blood, urine, or saliva. 

Perhaps one of the many things that make LFAs the leading test in this segment is the turnaround time. Lateral flow assays give nearly instant results. It is only beneficial in settings where fast decision-making is imperative. For their portability and lack of dependence on complex laboratory equipment for functioning, these tests can be highly effective in various settings, including home care, remote, or resource-limited settings. Besides, the COVID-19 pandemic has further propelled the requirement for lateral flow assays. They have served as the basic pillar of rapid testing strategies around the world and enabled mass testing and screening with a very efficient methodology.

Regional Snapshots

By region, Insights into the markets in North America, Europe, Asia-Pacific, Latin America and MEA. Historically, North America has always been the leader in POCT. This is primarily a result of the chronic disease conditions, such as diabetes, cardiovascular disorders, and cancers that need to be tested more frequently and easily. The region has well-built infrastructures of health care along with several major players like Abbott Laboratories, Danaher Corporation, Becton Dickinson, which also have been contributing to the high uptake of POCT in the region. Moreover, the strong emphasis on innovation and an early adoption of advanced diagnostics, such as molecular diagnostics and wearable monitoring devices, have been facilitating the advancement of POCT in North America. Government initiatives aimed at better access to healthcare and supporting reimbursement have also been instrumental in developing the POCT Market in this part of the region.

In the forecast period, Asia-Pacific is expected to remain the fastest-growing region in the world POCT Market, as the rise in population, the increase in chronic diseases, and the improvement in healthcare infrastructure are most robustly needed in this region, particularly in countries like China, India, and Japan. Meanwhile, growing awareness of early diagnosis and preventive healthcare coupled with increased health care expenditure are driving the demand for POCT devices in this region. Important factors include a middle-class growing population and decentralized healthcare, which will also contribute to the region's overall strong growth, positioning Asia-Pacific as a high-potential area for POCT Market development.

List of Companies Profiled

• Abbott Laboratories
• Roche Diagnostics
• Siemens Healthineers
• Danaher Corporation
• Becton, Dickinson and Company (BD)
• Johnson & Johnson
• bioMérieux
• Quidel Corporation
• Thermo Fisher Scientific
• Bio-Rad Laboratories
• Chembio Diagnostics
• Nova Biomedical
• EKF Diagnostics
• Trinity Biotech
• Werfen
• OraSure Technologies
• AccuBioTech
• Sekisui Diagnostics
• Abaxis (Zoetis)
• Instrumentation Laboratory (a Werfen Company)

Key Industry Developments

• In October 2024, Trinity Biotech plc, a commercialstage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, announced a strategic investment in Novus Diagnostics, a company pioneering a rapid sepsis testing platform. This investment will accelerate the development and commercialization of Novus’ groundbreaking point-of-care diagnostic solutions, including its 15-minute bloodstream infection test.
• In July 2024, Roche announced the completion of the acquisition of LumiraDx’s Point of Care technology, following the receipt of all required antitrust and regulatory clearances. Roche will now embark on the full integration of the company’s innovative multi-assay point of care platform and the related R&D, operational and commercial sites into its global organisation.

Report Coverage

The report will cover the qualitative and quantitative data on the Global Point of Care Testing Market. The qualitative data includes latest trends, market players analysis, market drivers, market opportunity, and many others. Also, the report quantitative data includes market size for every region, country, and segments according to your requirements. We can also provide customize report in every industry vertical.

Report Scope and Segmentations

Global Point of Care Testing Market Regional Analysis

North America accounted for the highest xx% market share in terms of revenue in the Point of Care Testing market and is expected to expand at a CAGR of xx% during the forecast period. This growth can be attributed to the growing adoption of Point of Care Testing. The market in APAC is expected to witness significant growth and is expected to register a CAGR of xx% over upcoming years, because of the presence of key Point of Care Testing companies in economies such as Japan and China.

The objective of the report is to present comprehensive analysis of Global Point of Care Testing Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language.

Point of Care Testing Market Report is also available for below Regions and Country Please Ask for that

North America

• U.S.
• Canada

Europe

• Switzerland
• Belgium
• Germany
• France
• U.K.
• Italy
• Spain
• Sweden
• Netherland
• Turkey
• Rest of Europe

Asia-Pacific

• India
• Australia
• Philippines
• Singapore
• South Korea
• Japan
• China
• Malaysia
• Thailand
• Indonesia
• Rest Of APAC

Latin America

• Mexico
• Argentina
• Peru
• Colombia
• Brazil
• Rest of South America

Middle East and Africa

• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest Of MEA

Points Covered in the Report

• The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
• The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analysed 12 years data history and forecast.
• The growth factors of the market are discussed in detail wherein the different end users of the market are explained in detail.
• Data and information by market player, by region, by type, by application and etc., and custom research can be added according to specific requirements.
• The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Key Reasons to Purchase

• To gain insightful analyses of the Point of Care Testing market and have comprehensive understanding of the global market and its commercial landscape.
• Assess the production processes, major issues, and solutions to mitigate the development risk.
• To understand the most affecting driving and restraining forces in the market and its impact in the global market.
• Learn about the Point of Care Testing market strategies that are being adopted by leading respective organizations.
• To understand the future outlook and prospects for the Point of Care Testing market. Besides the standard structure reports, we also provide custom research according to specific requirements.

Research Scope of Point of Care Testing Market

• Historic year: 2019-2022
• Base year: 2023
• Forecast: 2024 to 2032
• Representation of Market revenue in USD Million

Point of Care Testing Market Trends: Market key trends which include Increased Competition and Continuous Innovations Trends: